CH531492A - Antiinflammatory pregnene-diones - Google Patents
Antiinflammatory pregnene-dionesInfo
- Publication number
- CH531492A CH531492A CH860272A CH860272A CH531492A CH 531492 A CH531492 A CH 531492A CH 860272 A CH860272 A CH 860272A CH 860272 A CH860272 A CH 860272A CH 531492 A CH531492 A CH 531492A
- Authority
- CH
- Switzerland
- Prior art keywords
- beta
- pregnene
- acid
- methylene
- dione
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G01D9/00—Recording measured values
- G01D9/28—Producing one or more recordings, each recording being of the values of two or more different variables
- G01D9/30—Producing one or more recordings, each recording being of the values of two or more different variables there being a separate recording element for each variable, e.g. multiple-pen recorder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G01D18/00—Testing or calibrating apparatus or arrangements provided for in groups G01D1/00 - G01D15/00
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07C—TIME OR ATTENDANCE REGISTERS; REGISTERING OR INDICATING THE WORKING OF MACHINES; GENERATING RANDOM NUMBERS; VOTING OR LOTTERY APPARATUS; ARRANGEMENTS, SYSTEMS OR APPARATUS FOR CHECKING NOT PROVIDED FOR ELSEWHERE
- G07C3/00—Registering or indicating the condition or the working of machines or other apparatus, other than vehicles
- G07C3/08—Registering or indicating the production of the machine either with or without registering working or idle time
- G07C3/12—Registering or indicating the production of the machine either with or without registering working or idle time in graphical form
-
- G—PHYSICS
- G08—SIGNALLING
- G08G—TRAFFIC CONTROL SYSTEMS
- G08G1/00—Traffic control systems for road vehicles
- G08G1/01—Detecting movement of traffic to be counted or controlled
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Trihydroxypregnene-3,20-diones (I) and especially 11 beta, 17 alpha, 21-trihydroxy-15, 16 beta-methylene-pregnene (4)-(and pregna-1,4-diene)-3,20-dione, for use as anti-inflammatories. R6 and R9 independently are H, halogen, R17, R21 independently are OH or O-acyl; Z is CO or beta-CH2OH. Preparation of (I) and 1,2-dehydro-deriv. by numerous methods e.g. (a) microbiological 11-hydroxylation of (I) (Z=CH2); (b) 1,2-dehydrogenation of a cmpd. (I); (c) adding HOCl or HOBr to the 9,11-double bond a cmpd. (I) or its, 1,2-dehydro-derivs. (Z = HC). In an example 11 beta, 17 alpha-21-trihydroxy-15,16 beta-methylene-pregnene (4)-3,20-dione, m.p. 219-221 degrees is obtained by microbiological hydroxylation of 17 alpha, 21-dihydroxy-15,16 beta-methylene-pregnene (4)-3,20-dione using Coniothyrium hellebori as organism.
Description
Verfahren zur Herstellung neuer Steroide der Pregnanreihe
Die Erfindung betrifft ein Verfahren zur Herstellung neuer Steroide der Formel
EMI1.1
in der R6 und Rg unabhängig voneinander Wasserstoff, Fluor, Chlor oder Brom, R21 Hydroxy oder Acyloxy und Z Carbonyl oder ss-Hydroxymethylen bedeuten bzw. deren 1,2 Dehydroderivate.
Eine Acyloxygruppe enthält vorzugsweise den Rest einer gesättigten oder ungesättigten aliphatischen oder cycloaliphatischen, einer araliphatischen oder aromatischen Carbonsäure mit bis zu 20, vorzugsweise bis zu 12 C-Atomen. Beispiele solcher Säuren sind Ameisensäure, Essigsäure, Pivalinsäure, Propionsäure, Buttersäure, Capronsäure, Önanthsäure, Ölsäure, Palmitinsäure, Stearinsäure, Bernsteinsäure, Malonsäure, Fumarsäure, Zintronensäure, Cyclohexylpropionsäure, Phenylessigsäure und Benzoesäure.
Bevorzugte erfindungsgemäss erhältliche Verbindungen sind diejenigen, in denen R6 und R9 Wasserstoff oder Fluor, R21 Hydroxy und Z ,B-Hydroxymethylen darstellen.
Das erfindungsgemässe Verfahren ist dadurch gekennzeichnet, dass man ein Steroid der Formel
EMI1.2
worin R6, R9 und Z die obige Bedeutung besitzen und Ac einen Acylrest darstellt, oder das 1,2-Dehydroderivat eines solchen Steroids mindestens in der Stellung 17a verseift.
Zur Herstellung der Ausgangsstoffe kann auf die belgische Patentschrift Nr. 760 392 verwiesen werden.
Die erfindungsgemäss erhältlichen Steroide sind endocrin, insbesondere antiinflammatorisch, wirksam. Sie können als Heilmittel in Form pharmazeutischer Präparate Verwendung finden, welche sie in Mischung mit einem für die enterale, perkutane oder parenterale Applikation geeigneten pharmazeutischen, organischen oder anorganischen inerten Trägermaterial enthalten. Die pharmazeutischen Präparate können in fester Form, in halbfester oder in flüssiger Form vorliegen. Gegebenenfalls enthalten sie Hilfsstoffe, wie Konservierungs-, Stabilisierungs-, Netz- oder Emulgiermittel, Salze zur Veränderung des osmotischen Druckes oder Puffer.
Sie können auch noch andere therapeutisch wertvolle Stoffe enthalten.
Beispiel 1
300 mg 17a,21-Diacetoxy-l l-hydroxy-15ss,16P-methy- len-pregn-4-en-3,20-dion wurden in 30 ml Methanol gelöst und mit 150 mg NaHCO3 6 Stunden bei Raumtemperatur gerührt. Zur Aufarbeitung wurde auf Eiswasser gegossen und mit Methylenchlorid extrahiert. Der organische Extrakt wurde mit Wasser neutral gewaschen, mit Na2SO4 getrocknet und im Vakuum eingedampft. Der Rückstand wurde auf 30 g Silicagel chromatographiert. Mit Benzol-Propanol (95 :5) wurde zunächst reines 2 1-Acetoxy- 11ss, 17a-dihydroxy- lSss,16ss-methylen-pregn-4-en-3,20-dion eluiert. Die nachfolgenden Fraktionen lieferten llss,17a,21-Trihydroxy- 15ss,16ss-methylen-pregn-4-en-3,20-dion, Smp. 218-220" C.
Beispiel 2
921 mg 21-Acetoxy-17-hydroxy-lSss,16ss-methylen-pregn- 4-en-3,11,20-trion und 46 mg Kaliumcarbonat wurden in 25 ml Methanol gelöst und 2 Stunden bei Raumtemperatur gerührt. Zur Aufarbeitung goss man auf Eiswasser und extrahierte mit Methylenchlorid. Durch Neutralwaschen mit Wasser, Trocknen mit Na2SO4 und Eindampfen des Lösungsmittels im Vakuum wurden aus dem organischen Extrakt 863 mg Rohprodukt erhalten. Dieses wurde auf Silicagel chromatographiert. Mit Benzol-Propanol (9: 1) wurde reines 17,21-Dihydroxy-lSss,16ss-methylen-pregn-4-en-3,11,20-trion isoliert. Schmelzpunkt 217O (Zers.). [a]D25 = + 180 (c=0,1 in Dioxan).
Process for the production of new steroids of the Pregnan range
The invention relates to a process for the preparation of new steroids of the formula
EMI1.1
in which R6 and Rg independently of one another are hydrogen, fluorine, chlorine or bromine, R21 is hydroxy or acyloxy and Z is carbonyl or ß-hydroxymethylene or 1,2 dehydro derivatives thereof.
An acyloxy group preferably contains the residue of a saturated or unsaturated aliphatic or cycloaliphatic, an araliphatic or aromatic carboxylic acid having up to 20, preferably up to 12, carbon atoms. Examples of such acids are formic acid, acetic acid, pivalic acid, propionic acid, butyric acid, caproic acid, enanthic acid, oleic acid, palmitic acid, stearic acid, succinic acid, malonic acid, fumaric acid, tintronic acid, cyclohexylpropionic acid, phenylacetic acid and benzoic acid.
Preferred compounds obtainable according to the invention are those in which R6 and R9 are hydrogen or fluorine, R21 is hydroxy and Z, B-hydroxymethylene.
The method according to the invention is characterized in that a steroid of the formula
EMI1.2
where R6, R9 and Z have the above meaning and Ac is an acyl radical, or the 1,2-dehydro derivative of such a steroid is saponified at least in the 17a position.
For the preparation of the starting materials, reference can be made to Belgian patent specification No. 760 392.
The steroids obtainable according to the invention are endocrine, in particular anti-inflammatory, effective. They can be used as remedies in the form of pharmaceutical preparations which they contain as a mixture with a pharmaceutical, organic or inorganic inert carrier material suitable for enteral, percutaneous or parenteral administration. The pharmaceutical preparations can be in solid, semi-solid or liquid form. They may contain auxiliaries, such as preservatives, stabilizers, wetting agents or emulsifiers, salts to change the osmotic pressure or buffers.
They can also contain other therapeutically valuable substances.
example 1
300 mg of 17a, 21-diacetoxy-11-hydroxy-15ss, 16P-methylene-pregn-4-en-3,20-dione were dissolved in 30 ml of methanol and stirred with 150 mg of NaHCO3 for 6 hours at room temperature. For work-up, it was poured onto ice-water and extracted with methylene chloride. The organic extract was washed neutral with water, dried with Na2SO4 and evaporated in vacuo. The residue was chromatographed on 30 g of silica gel. With benzene-propanol (95: 5), pure 2 1-acetoxy-11ss, 17a-dihydroxy-lSss, 16ss-methylen-pregn-4-en-3,20-dione was first eluted. The following fractions yielded 11ss, 17a, 21-trihydroxy-15ss, 16ss-methylen-pregn-4-en-3,20-dione, m.p. 218-220 "C.
Example 2
921 mg of 21-acetoxy-17-hydroxy-lSss, 16ss-methylene-pregn-4-en-3,11,20-trione and 46 mg of potassium carbonate were dissolved in 25 ml of methanol and stirred for 2 hours at room temperature. For work-up, it was poured into ice water and extracted with methylene chloride. By washing neutral with water, drying with Na2SO4 and evaporating the solvent in vacuo, 863 mg of crude product were obtained from the organic extract. This was chromatographed on silica gel. With benzene-propanol (9: 1), pure 17,21-dihydroxy-lSss, 16ss-methylene-pregn-4-ene-3,11,20-trione was isolated. Melting point 2170 (dec.). [a] D25 = +180 (c = 0.1 in dioxane).
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH860272A CH531492A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH860272A CH531492A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH1883169A CH525872A (en) | 1969-12-17 | 1969-12-17 | Process for the production of new steroids of the Pregnan range |
Publications (1)
Publication Number | Publication Date |
---|---|
CH531492A true CH531492A (en) | 1972-12-15 |
Family
ID=4435537
Family Applications (11)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH860072A CH531491A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860672A CH531486A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860372A CH531493A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH859972A CH531490A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH859772A CH531485A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860472A CH531494A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860172A CH531487A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH1883169A CH525872A (en) | 1969-12-17 | 1969-12-17 | Process for the production of new steroids of the Pregnan range |
CH860272A CH531492A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH859872A CH529734A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860572A CH531495A (en) | 1969-12-17 | 1970-10-30 | Antiinflammatory pregnene-diones |
Family Applications Before (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH860072A CH531491A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860672A CH531486A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860372A CH531493A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH859972A CH531490A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH859772A CH531485A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860472A CH531494A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860172A CH531487A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH1883169A CH525872A (en) | 1969-12-17 | 1969-12-17 | Process for the production of new steroids of the Pregnan range |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH859872A CH529734A (en) | 1969-12-17 | 1969-12-17 | Antiinflammatory pregnene-diones |
CH860572A CH531495A (en) | 1969-12-17 | 1970-10-30 | Antiinflammatory pregnene-diones |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS4920774B1 (en) |
AT (8) | AT315397B (en) |
BE (1) | BE760392A (en) |
CA (1) | CA955931A (en) |
CH (11) | CH531491A (en) |
DE (1) | DE2061183C3 (en) |
ES (2) | ES386503A1 (en) |
FI (1) | FI47484C (en) |
FR (1) | FR2081369B1 (en) |
GB (1) | GB1276419A (en) |
HU (1) | HU162802B (en) |
IE (1) | IE34816B1 (en) |
IL (1) | IL35790A (en) |
NL (1) | NL7016761A (en) |
NO (1) | NO135528C (en) |
YU (1) | YU34700B (en) |
ZA (1) | ZA708096B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2740344A (en) * | 1951-12-05 | 1956-04-03 | Messrs Lumoprint Zindler K G | Device for treating directly exposed photopapers |
DE2453823C2 (en) * | 1974-11-11 | 1984-08-09 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11β, 17α-dihydroxy-15α, 16α-methylene-1,4-pregnadiene-3,20-dione |
JPS56109115A (en) * | 1980-12-05 | 1981-08-29 | Fukui Kikai Kk | Controlling method for feeder for strip material |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3438975A (en) * | 1966-07-01 | 1969-04-15 | Syntex Corp | 15alpha,16alpha-methylene pregnanes and 19-nor-pregnanes |
CH503712A (en) * | 1968-04-22 | 1971-02-28 | Hoffmann La Roche | Hormone active steroids |
-
1969
- 1969-12-17 CH CH860072A patent/CH531491A/en not_active IP Right Cessation
- 1969-12-17 CH CH860672A patent/CH531486A/en not_active IP Right Cessation
- 1969-12-17 CH CH860372A patent/CH531493A/en not_active IP Right Cessation
- 1969-12-17 CH CH859972A patent/CH531490A/en not_active IP Right Cessation
- 1969-12-17 CH CH859772A patent/CH531485A/en not_active IP Right Cessation
- 1969-12-17 CH CH860472A patent/CH531494A/en not_active IP Right Cessation
- 1969-12-17 CH CH860172A patent/CH531487A/en not_active IP Right Cessation
- 1969-12-17 CH CH1883169A patent/CH525872A/en not_active IP Right Cessation
- 1969-12-17 CH CH860272A patent/CH531492A/en not_active IP Right Cessation
- 1969-12-17 CH CH859872A patent/CH529734A/en not_active IP Right Cessation
-
1970
- 1970-10-30 CH CH860572A patent/CH531495A/en not_active IP Right Cessation
- 1970-11-14 IE IE1600/70A patent/IE34816B1/en unknown
- 1970-11-16 NL NL7016761A patent/NL7016761A/xx unknown
- 1970-11-26 FI FI703190A patent/FI47484C/en active
- 1970-11-30 ZA ZA708096*A patent/ZA708096B/en unknown
- 1970-12-02 HU HUHO1335A patent/HU162802B/hu unknown
- 1970-12-04 IL IL35790A patent/IL35790A/en unknown
- 1970-12-07 YU YU2980/70A patent/YU34700B/en unknown
- 1970-12-10 CA CA100,261A patent/CA955931A/en not_active Expired
- 1970-12-11 DE DE2061183A patent/DE2061183C3/en not_active Expired
- 1970-12-15 GB GB59497/70A patent/GB1276419A/en not_active Expired
- 1970-12-16 AT AT675672A patent/AT315397B/en not_active IP Right Cessation
- 1970-12-16 AT AT675472A patent/AT315396B/en not_active IP Right Cessation
- 1970-12-16 FR FR7045351A patent/FR2081369B1/fr not_active Expired
- 1970-12-16 AT AT675172A patent/AT315395B/en not_active IP Right Cessation
- 1970-12-16 AT AT675772A patent/AT316774B/en active
- 1970-12-16 JP JP45111944A patent/JPS4920774B1/ja active Pending
- 1970-12-16 AT AT1130470A patent/AT308292B/en not_active IP Right Cessation
- 1970-12-16 AT AT675372A patent/AT316772B/en not_active IP Right Cessation
- 1970-12-16 BE BE760392A patent/BE760392A/en unknown
- 1970-12-16 NO NO4845/70A patent/NO135528C/no unknown
- 1970-12-16 AT AT675272A patent/AT316771B/en active
- 1970-12-16 AT AT675572A patent/AT316773B/en not_active IP Right Cessation
- 1970-12-16 ES ES386503A patent/ES386503A1/en not_active Expired
-
1972
- 1972-06-10 ES ES403723A patent/ES403723A2/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2314592C2 (en) | D-homo-steroids, process for their production and preparations containing them | |
CH531492A (en) | Antiinflammatory pregnene-diones | |
CH625809A5 (en) | Process for the preparation of polyhalogenated steroids | |
CH505080A (en) | Hormone active steroids | |
DE1250821B (en) | Process for the preparation of 17a-hydroxy-3-keto- / 14-pregnen-17-acylates | |
DE2144405A1 (en) | Saponification of pregnane series esters - using silica gel | |
AT361644B (en) | METHOD FOR PRODUCING NEW D-HOMOSTEROIDS | |
DE1618936C3 (en) | Process for the preparation of fluorine compounds of the pregnancy series. Eliminated from: 1418394 Anmr Syntex S.A., Mexico City | |
CH508611A (en) | Process for the 17a-alkylation of 20-keto steroids of the pregnane series | |
DE1493313C (en) | 16b, 17 cycloenol ethers of 17alpha hydroxy öalpha methyl 3.20 dioxo 4 pregnen 16alpha acetaldehyde and des 1 lbeta, 17alpha dihydroxy 9alpha fluorine 6alpha methyl 3.20 dioxo 1,4 pregnadiene 16alpha acetaldehyde and process for their preparation | |
AT236040B (en) | Process for the preparation of 3-hydroxy-9 (11), 16-pregnadien-20-one, 3, 11Β-dihydroxy-16-pregnen-20-one and C-3 esters of these compounds | |
AT369388B (en) | METHOD FOR PRODUCING NEW D-HOMOSTEROIDS | |
AT231618B (en) | Process for the preparation of 1, 4, 9 (11) -unsaturated compounds of the pregnane series | |
DE1113453B (en) | Process for the production of substitution products of Reichsteins-Substance-S or their 21-acylates | |
CH499505A (en) | Steroids of the partial formula (I):- where R1 is halogen (at wt.100) or alkyl Q is oxo or 1,2-alkylenedioxy (2-4C) M is the remainder of the | |
CH606115A5 (en) | 9-Alpha-11-beta-dihalo-D-homo-pregn-4-en-3,20-diones | |
CH527808A (en) | 9beta 10alpha-steroids progestatives | |
CH553759A (en) | PROCESS FOR THE PREPARATION OF NEW 4-CHLORO-1,2 (ALPHA) -METHYLENE (DELTA) 4,6-PREGNADIEN-17 (ALPHA) -OL-3,20-Dione, OR ITS 17ESTER. | |
DE1443176A1 (en) | 6 alpha-fluoro-16-beta-methyl-4-pregnene and -1,4-pregnadienes and process for their preparation | |
CH606114A5 (en) | 9-Alpha-11-beta-dihalo-D-homo-pregn-4-en-3,20-diones | |
CH330672A (en) | Method of making steroids | |
CH507925A (en) | 19-alkyl steroids | |
CH623339A5 (en) | Process for the preparation of D-homosteroids | |
DE1048915B (en) | Process for the preparation of 6-methyl-9ª ‡, 21-difluoro-11ª ‰, 17ª ‡ -dioxy-1,4-pregnadiene-3,20-dione and its 11-keto analogues | |
CH571022A5 (en) | D-homo-corticosteroids - anti-inflammatories |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |